IPO
Angelini Pharma's $4.1 Billion Acquisition of Catalyst Pharmaceuticals Explained
Angelini Pharma's acquisition of Catalyst Pharmaceuticals for $4.1 billion marks a major strategic move in the U.S. healthcare market.
May 7, 2026
Technology
QuasarEdge's Potential SPAC Merger with Robseek Intelligence: What Investors Should Know
QuasarEdge's SPAC merger with Robseek Intelligence could reshape the intelligence tech landscape. Here’s what investors …
May 7
Economy
Gold Prices Surge Amid Geopolitical Optimism: A Look at Market Trends
Spot gold prices reached two-week highs as hopes for a US-Iran deal influence market dynamics.
May 7
Analysis
Apollo Funds Takes a Bite Out of the Food Sector with Prosol Group Acquisition
Apollo Funds solidifies its foothold in the food sector by acquiring a majority stake in Prosol Group, signaling strong …
May 7
Free Newsletter
Informed positions start with informed mornings.
Market-moving analysis and institutional-grade research, complimentary and delivered daily.
More Stories
